Please ensure Javascript is enabled for purposes of website accessibility

Here's What Investors Should Know Heading Into Procter & Gamble's Q1 Earnings

By Parkev Tatevosian, CFA – Oct 13, 2021 at 10:30AM

Key Points

  • Wall Street expects P&G to report revenue of $19.8 billion and earnings per share of $1.58.
  • Management is guiding to revenue growth of 3% and EPS growth of 7.5% for fiscal 2022.
  • The stock is trading at a price-to-earnings ratio of 25, which is near its historic average.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The international conglomerate will report earnings on Oct. 19.

Global consumer packaged-goods giant Procter & Gamble (PG 0.06%) will report first-quarter fiscal 2022 earnings on Tuesday, Oct. 19. The company is coming off a solid year in fiscal 2021 when consumers who were spending more time at home bought more of its products.

Fiscal 2022 will bring new challenges as well as some of the same from 2021. The world is cautiously learning to live with the presence of COVID-19, and economies are emerging from lockdowns in phases. Throughout the pandemic, consumer demand has increased and remained elevated while supply chains were negatively affected. P&G's ability to deal with these bottlenecks is the primary issue investors should focus on in its upcoming report. 

A person cleaning their desk.

Image source: Getty Images.

Procter & Gamble is facing inflation head on

Management sounded optimistic heading into the current quarter. Here's what it said in its July 30th press release:

We delivered another year of strong results with balanced top and bottom-line growth and strong cash generation, exceeding each of our in-going targets. We built strong momentum prior to the pandemic and have strengthened our position further. As we look forward to fiscal 2022, we expect to continue to grow top-line and bottom-line and to deliver another year of strong cash return to shareholders despite a challenging cost and operating environment. 

Indeed, the company is guiding investors to look for revenue growth of approximately 3% and earnings-per-share growth of 7.5% in fiscal 2022. The expected revenue growth is better than the negative 0.6% compound annual growth it delivered over the past decade. And the EPS growth will be impressive considering the rising costs throughout world economies.

In fact, management is estimating that rising commodity and freight expenses will cost the company $1.9 billion in 2022. Procter & Gamble's sales were $76 billion in 2021, so $1.9 billion is not an insignificant sum. Interestingly, the company went through 2021 with few price increases instituted across its portfolio of products. Even in its most recent quarter, the company's overall price increase was just 1% from the same period last year.

Look for the pace of those price increases to accelerate, starting with this quarter's report on Oct. 19. The company has already signaled it would be raising prices in the hope that competitors will also raise prices and it does not lose market share. It remains to be seen how that market share evolves as the inflationary pressures hit P&G and its competitors. My early estimate is that consumers will bear the brunt of higher costs as most companies will choose to raise prices. 

Procter & Gamble is trading at a fair valuation

So what does this all mean for results in the current quarter? Right now, analysts on Wall Street expect Procter & Gamble to report revenue of $19.8 billion and earnings per share of $1.58. If the company hits those estimates, it would mark an 8% increase in revenue from last year but a 3% decline in earnings per share. That is not such a concern since rising costs are hitting the company earlier in the year while the benefits of price increases on its products will help later.

As for P&G shares, they are presently trading at a price-to-earnings ratio of 25, right around their historical average. So in my view, there is no need for investors to buy the stock ahead of earnings. Wait for the results to come out, digest the latest information, and then make a decision.

Parkev Tatevosian has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Stocks Mentioned

Procter & Gamble Stock Quote
Procter & Gamble
$149.25 (0.06%) $0.09

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.